Harm H.H. Feringa

4.1k total citations
68 papers, 2.4k citations indexed

About

Harm H.H. Feringa is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Harm H.H. Feringa has authored 68 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Cardiology and Cardiovascular Medicine, 39 papers in Surgery and 32 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Harm H.H. Feringa's work include Cardiac, Anesthesia and Surgical Outcomes (38 papers), Aortic aneurysm repair treatments (20 papers) and Cardiac Imaging and Diagnostics (18 papers). Harm H.H. Feringa is often cited by papers focused on Cardiac, Anesthesia and Surgical Outcomes (38 papers), Aortic aneurysm repair treatments (20 papers) and Cardiac Imaging and Diagnostics (18 papers). Harm H.H. Feringa collaborates with scholars based in Netherlands, United States and Poland. Harm H.H. Feringa's co-authors include Don Poldermans, Jeroen J. Bax, Olaf Schouten, Eric Boersma, Martin Dunkelgrün, Radosav Vidaković, Sanne E. Hoeks, Miklós D. Kertai, Marc R.H.M. van Sambeek and Peter G. Noordzij and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Kidney International.

In The Last Decade

Harm H.H. Feringa

66 papers receiving 2.3k citations

Peers

Countries citing papers authored by Harm H.H. Feringa

Since Specialization

Citations

This map shows the geographic impact of Harm H.H. Feringa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harm H.H. Feringa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harm H.H. Feringa more than expected).

Fields of papers citing papers by Harm H.H. Feringa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harm H.H. Feringa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harm H.H. Feringa. The network helps show where Harm H.H. Feringa may publish in the future.

Co-authorship network of co-authors of Harm H.H. Feringa

This figure shows the co-authorship network connecting the top 25 collaborators of Harm H.H. Feringa. A scholar is included among the top collaborators of Harm H.H. Feringa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harm H.H. Feringa. Harm H.H. Feringa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Echocardiographic screening results in patients with tuberous sclerosis complex. 2010 ·PubMed ·Miraude Adriaensen, Maarten J. Cramer, (unknown), Cornelia Schaefer‐Prokop, Mathias Prokop, Pieter A. Doevendans, Bernard A. Zonnenberg, Harm H.H. Feringa	4
2	Focal Fatty Areas in the Myocardium of Patients With Tuberous Sclerosis Complex 2010 ·Journal of Thoracic Imaging ·Miraude Adriaensen, Harm H.H. Feringa, Cornelia Schaefer‐Prokop, Sandra Cornelissen, Bernard A. Zonnenberg, Mathias Prokop	3
3	Distal renal tubular acidosis in lymphoplasmacytic lymphoma Waldenström's macroglobulinemia: a case report 2009 ·Cases Journal ·Harm H.H. Feringa, (unknown), (unknown)	1
4	Abstract 2886: Fluvastatin Xl Use Is Associated With Improved Cardiac Outcome After Major Vascular Surgery. Results From A Randomized Placebo Controlled Trial: Decrease III 2008 ·Circulation ·Don Poldermans, Olaf Schouten, (unknown), Hero van Urk, Hence J.M. Verhagen, (unknown), Harm H.H. Feringa, Martin Dunkelgrün, Jeroen J. Bax, Eric Boersma	8
5	Pre-Operative Risk Assessment and Risk Reduction Before Surgery 2008 ·Journal of the American College of Cardiology ·Don Poldermans, Sanne E. Hoeks, Harm H.H. Feringa	87
6	Intensity of Statin Therapy in Relation to Myocardial Ischemia, Troponin T Release, and Clinical Cardiac Outcome in Patients Undergoing Major Vascular Surgery 2007 ·Journal of the American College of Cardiology ·Harm H.H. Feringa, Olaf Schouten, Stefanos Karagiannis, Jasper J. Brugts, Abdou Elhendy, Eric Boersma, Radosav Vidaković, Marc R.H.M. van Sambeek, Peter G. Noordzij, Jeroen J. Bax, Don Poldermans	23
7	The effect of intensified lipid-lowering therapy on long-term prognosis in patients with peripheral arterial disease 2007 ·Journal of Vascular Surgery ·Harm H.H. Feringa, Stefanos Karagiannis, (unknown), Eric Boersma, Olaf Schouten, Jeroen J. Bax, Don Poldermans	74
8	Prognostic Significance of Declining Ankle-brachial Index Values in Patients with Suspected or Known Peripheral Arterial Disease 2007 ·European Journal of Vascular and Endovascular Surgery ·Harm H.H. Feringa, (unknown), (unknown), (unknown), (unknown), Eric Boersma, (unknown), J. J. Bax, (unknown)	29
9	Plasma N-Terminal Pro-B-Type Natriuretic Peptide as a Long-Term Prognostic Marker After Major Vascular Surgery 2007 ·Journal of Vascular Surgery ·Harm H.H. Feringa, Olaf Schouten, Martin Dunkelgrün	3
10	A Clinical Randomized Trial to Evaluate the Safety of a Noninvasive Approach in High-Risk Patients Undergoing Major Vascular Surgery 2007 ·Journal of the American College of Cardiology ·Don Poldermans, Olaf Schouten, Radosav Vidaković, Jeroen J. Bax, Ian R. Thomson, Sanne E. Hoeks, Harm H.H. Feringa, Martin Dunkelgrün, Peter de Jaegere, Alexander P.W.M. Maat, Marc R.H.M. van Sambeek, Miklós D. Kertai, Eric Boersma	215
11	Abstract 1898: A Prognostic Risk Index Predicts Long-Term Mortality in Patients with Peripheral Arterial Disease 2006 ·Circulation ·Harm H.H. Feringa, (unknown), (unknown), Jeroen J. Bax, Eric Boersma, Olaf Schouten, Peter G. Noordzij, Martin Dunkelgrün, Stefanos Karagiannis, Radosav Vidaković, Don Poldermans	1
12	Myocardial Viability Estimation During the Recovery Phase of Stress Echocardiography After Acute Beta-Blocker Administration 2006 ·European Journal of Heart Failure ·Stefanos Karagiannis, Harm H.H. Feringa, Jeroen J. Bax, (unknown), Martin Dunkelgrün, Radosav Vidaković, Sanne E. Hoeks, Ron van Domburg, (unknown), Dennis V. Cokkinos, Don Poldermans	1
13	Cardioprotective Medication Is Associated With Improved Survival in Patients With Peripheral Arterial Disease 2006 ·Journal of the American College of Cardiology ·Harm H.H. Feringa, (unknown), Jeroen J. Bax, Abdou Elhendy, Eric Boersma, Olaf Schouten, Wael Galal, Radosav Vidaković, Marco J.D. Tangelder, Don Poldermans	117
14	Statins are Associated with a Reduced Infrarenal Abdominal Aortic Aneurysm Growth 2006 ·European Journal of Vascular and Endovascular Surgery ·Olaf Schouten, Jorinde H.H. van Laanen, Eric Boersma, Radosav Vidaković, Harm H.H. Feringa, Martin Dunkelgrün, Jeroen J. Bax, Jos J. de Koning, Hero van Urk, Don Poldermans	199
15	Abdominal Aortic Aneurysm Screening Using Non-imaging Hand-held Ultrasound Volume Scanner – A Pilot Study 2006 ·European Journal of Vascular and Endovascular Surgery ·Radosav Vidaković, Olaf Schouten, Harm H.H. Feringa, Martin Dunkelgrün, (unknown), (unknown), Jacobus J. Bosch, (unknown), Aleksandar Nešković, Jeroen J. Bax, Don Poldermans	5
16	Hemodynamic responses and long-term follow-up results in patients using chronic beta 1-selective and nonselective beta-blockers during dobutamine stress echocardiography 2006 ·Coronary Artery Disease ·Harm H.H. Feringa, Jeroen J. Bax, Abdou Elhendy, Ron T. van Domburg, Olaf Schouten, Boudewijn J. Krenning, Don Poldermans	1
17	A meta-analysis of safety and effectiveness of perioperative beta-blocker use for the prevention of cardiac events in different types of noncardiac surgery 2006 ·Coronary Artery Disease ·Olaf Schouten, Leslee J. Shaw, Eric Boersma, Jeroen J. Bax, Miklós D. Kertai, Harm H.H. Feringa, Elena Biagini, Niels F. M. Kok, Hero van Urk, Abdou Elhendy, Don Poldermans	35
18	Statins for the prevention of perioperative cardiovascular complications in vascular surgery 2006 ·Journal of Vascular Surgery ·Olaf Schouten, Jeroen J. Bax, Martin Dunkelgrün, Harm H.H. Feringa, Hero van Urk, Don Poldermans	34
19	β-Blockers Improve In-hospital and Long-term Survival in Patients with Severe Left Ventricular Dysfunction Undergoing Major Vascular Surgery 2005 ·European Journal of Vascular and Endovascular Surgery ·Harm H.H. Feringa, Jeroen J. Bax, Olaf Schouten, Miklós D. Kertai, Louis L.M. van de Ven, Sanne E. Hoeks, Marc R.H.M. van Sambeek, Jan Klein, Don Poldermans	13
20	Perioperative and Long-Term Cardiovascular Outcomes in Patients Undergoing Endovascular Treatment Compared With Open Vascular Surgery for Abdominal Aortic Aneurysm or Iliaco-Femoro-Popliteal Bypass 2005 ·The American Journal of Cardiology ·Olaf Schouten, (unknown), Miklós D. Kertai, Harm H.H. Feringa, Jeroen J. Bax, Eric Boersma, Abdou Elhendy, Elena Biagini, Marc R.H.M. van Sambeek, Hero van Urk, Don Poldermans	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact